Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Tetravalent protein vaccine against Staphylococcus aureus
3rd International Conference on Vaccines & Vaccination
July 29-31, 2013 Embassy Suites Las Vegas, NV, USA

Nisha Nair and Raja Biswas

Young Research Forum: J Vaccines Vaccin

Abstract:

S taphylococcus aureus causes wide range of diseases from minor infections to life-threatening sepsis, endocarditis, and pneumonia. Several antigens have been identified so far as vaccine that, either alone or in combination have the ability to reduce S. aureus (including multi drug resistant strains) colonization in animal models but with little success. Here we explored the possibility of designing a vaccine based on non-covalently surface associated proteins (NCSPs) of S. aureus. The known NCSPs [GM, Aaa, LytM, IsaB, SEM, SsA, Amidase(AM), LytR, LytN ,and SAV-1056] were cloned and expressed in E. coli as N-terminal histidine tagged protein and purified using Ni-NTA chromatography. The antigenicity of these proteins was tested against sera from S. aureus infected mice using ELISA and immunogenicity tested using mice splenocyte proliferation assay. All the NCSPs were antigenic and immunogenic; however the degree differed among NCSPs. The shortlisted proteins, with high homology score across different S. aureus strains, were used for vaccination study in BALB/c mice. The selected proteins were found to trigger Th1 response in splenocyte proliferation assay. Upon vaccination with a cocktail of NSCPs in BALB/c mice, we observed that all the vaccinated mice survived till the 9 th day, and 6 survived till day 14 (75% survival). Only 1 out of 8 non-vaccinated mice survived after lethal challenge with S. aureus . There was 6-7 fold reduction in the bacterial load in internal organs of vaccinated mice. The sera of the vaccinated mice were capable of inducing opsonophagocytosis of S. aureus by human polymorphonuclear leukocytes.

Biography :

Nisha Nair is currently undergoing her Ph.D. program in the field of Infectious Diseases at Amrita Center for Nanosciences and Molecular medicine, AIMS, Kochi. She has been awarded with senior research fellowship by Indian Council of Medical Research, India. She has two second author publications to her credit and her main work yet to be published.